sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > BTK
BTK
Cat.No. Product Name Information Area
T4387 evobrutinib Evobrutinib, also known as M-2951 and MSC-2364447C, is a highly selective inhibitor o...
T4337 PCI-29732 PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET...
T3626 Acalabrutinib Acalabrutinib, also known as ACP-196, is an orally available inhibitor of Bruton’s ty... Cancer
T6921 ONO-4059 analogue ONO-4059 analogue is an analogue of ONO-4059, which is a highly potent and selective ... Others
T6217 LFM-A13 LFM-A13(IC50=2.5 μM),a specific Bruton's tyrosine kinase (BTK), is more than 100-fold... Cancer
T2699 BMS-777607 BMS-777607 is a Met-related inhibitor for c-Met/Axl/Ron/Tyro3 (IC50: 3.9/1.1/1.8/4.3 ... Endocrine system
T2603 CC-292 (AVL-292) Spebrutinib is an orally bioavailable, selective inhibitor of Bruton's agammaglobulin... Cancer
T2472 CGI1746 CGI1746 is a potent and highly selective small-molecule Btk inhibitor with IC50 of 1.... Cancer
T2302 CNX-774 CNX-774 is a highly specific, irreversible, and orally active BTK inhibitor (IC50<1 n... Other
T1976 RN486 RN486 is an effective and specific BTK inhibitor (IC50: 4 nM). Other
T1835 PCI-32765hot Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton's tyrosine ki... Cancer
1